Patent Term Extension Application for Equidone® Gel (domiperidone), U.S. Patent No. 5,372,818 - CLOSED

Docket ID: FDA-2011-E-0139
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Status: CLOSED
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Keyword(s): 5,372,818, domiperidone, Equidone® Gel , Patent Extension Application
Type: Nonrulemaking
Docket Status: CLOSED
Center: CDER
Docket Item Code: E

Primary Documents

View All  (10)
Comment Period Closed
Jul 03, 2012 11:59 PM ET
Posted: 05/04/2012
ID: FDA-2011-E-0139-0006
Comment Period Closed
Posted: 04/04/2014
ID: FDA-2011-E-0139-0010
Comment Period Closed
Posted: 11/04/2013
ID: FDA-2011-E-0139-0009
Comment Period Closed
Posted: 04/29/2013
ID: FDA-2011-E-0139-0008
Comment Period Closed
Posted: 12/28/2012
ID: FDA-2011-E-0139-0007

Supporting Documents

No documents available.


No comments posted.

Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.